Female Hormonal Health
From puberty to post-menopause, female hormonal health involves dramatic cyclical changes every month, a decade-long transition in midlife, and a complete hormonal reorganisation afterwards. Each stage has distinct biology, distinct risks, and distinct opportunities to act.
The five stages of female hormonal health
Sex hormones remain very low throughout childhood. The hypothalamic-pituitary axis is suppressed — the reproductive system is present but not yet active. Growth hormone and thyroid hormones drive development.
- →Rapid physical growth driven by GH and IGF-1
- →Brain development heavily dependent on thyroid hormones
- →Adrenal glands begin producing small amounts of androgens from around age 6–8 (adrenarche)
- ⚠Early or delayed puberty (precocious puberty before age 8)
- ⚠Growth hormone deficiency affecting height and body composition
- ⚠Congenital hypothyroidism — if missed, impacts neurological development
The hypothalamus awakens from its childhood suppression and begins pulsing GnRH, triggering the pituitary to release FSH and LH. The ovaries respond with estrogen, then progesterone once cycles are established. This activates the full reproductive system.
- →Breast development, pubic hair, growth spurt (driven by estrogen and GH)
- →First period (menarche) — average age 12, range 9–15
- →Cycles often irregular for 2–3 years as the HPO axis matures
- →Acne, oiliness — driven by rising androgens (testosterone, DHEA)
- →Brain changes: emotional sensitivity, reward-seeking — dopamine and serotonin remodelled by estrogen
- ⚠Irregular periods persisting beyond 3 years post-menarche (may signal PCOS or hypothyroidism)
- ⚠Absence of periods by age 15 (primary amenorrhoea)
- ⚠Severe mood disruption — PMDD can emerge at first ovulatory cycles
- ⚠Acne unresponsive to topical treatment (consider androgen excess)
The HPO axis runs a monthly cycle: estrogen rises in the follicular phase, peaks at ovulation (triggering the LH surge), then progesterone rises in the luteal phase. This cycle affects mood, energy, cognition, appetite, and sleep in ways that are often unrecognised.
- →Monthly cycle: follicular (estrogen ↑) → ovulation → luteal (progesterone ↑) → menstruation
- →Premenstrual symptoms (PMS/PMDD) driven by progesterone withdrawal and estrogen fluctuation
- →Fertility peaks in mid-20s; egg quality and quantity begin declining from ~32
- →AMH begins falling — the first measurable sign of ovarian ageing
- →Pregnancy: dramatic hormonal surges, then postpartum crash (hCG, progesterone, prolactin)
- ⚠PCOS — androgen excess, insulin resistance, irregular cycles affecting 8–13% of women (prevalence varies by diagnostic criteria used)
- ⚠Endometriosis — estrogen-driven tissue growth outside the uterus
- ⚠PMDD — severe luteal-phase mood disruption, distinct from normal PMS
- ⚠Postpartum depression — progesterone and estrogen crash after delivery
- ⚠Thyroid disorders — peak incidence during and after pregnancy
The ovarian follicle pool depletes. Estrogen and progesterone no longer follow a predictable cycle — they surge and crash unpredictably. The HPO, HPA, and metabolic axes all destabilise simultaneously. This is the most complex and most under-recognised hormonal transition.
- →Hot flashes, night sweats — hypothalamic thermoregulation disrupted by LH surges
- →Sleep disruption — progesterone loss, night sweats, cortisol dysregulation
- →Mood changes, anxiety — loss of progesterone's GABA-A calming effect
- →Cognitive changes — estrogen's role in serotonin and memory pathways
- →Cycle changes — shorter cycles, then longer, then skipped
- →Metabolic shift — insulin resistance, visceral fat, cholesterol changes
- ⚠Bone density baseline (DXA scan)
- ⚠Cardiovascular risk markers (lipids, blood pressure, fasting glucose)
- ⚠Thyroid — autoimmune thyroid disease peaks at this stage
- ⚠Early dismissal by clinicians — average delay to diagnosis is 3+ years
12 months after the last period, menopause is confirmed. Estrogen and progesterone are now consistently low. The adrenal glands and fat tissue become the primary source of sex hormones (via DHEA → estrone conversion). Metabolic, cardiovascular, and skeletal health become the central priorities.
- →Vasomotor symptoms (hot flashes) may persist for 7–10+ years in many women
- →Bone loss accelerates for 5–7 years post-menopause
- →Cardiovascular risk rises sharply — LDL rises, HDL falls, arteries stiffen
- →Genitourinary syndrome: vaginal atrophy, urinary urgency, recurrent UTIs
- →Cognitive changes — brain adapts to new lower estrogen baseline
- →Metabolic syndrome risk peaks — insulin resistance, visceral fat, lipid changes
- ⚠Osteoporosis — bone density monitoring essential
- ⚠Cardiovascular disease — now the leading cause of death in post-menopausal women
- ⚠Metabolic syndrome and type 2 diabetes
- ⚠Urogenital atrophy — often untreated and underreported
- ⚠Depression — distinct from pre-existing mood disorders
Perimenopause — the most in-depth section
Perimenopause is the most complex and most under-recognised female hormonal transition. The average woman sees multiple doctors over 3+ years before receiving an accurate explanation. This section covers all 10 symptom clusters, the staging timeline, all evidence-rated treatments, and a complete lab guide — in plain language.
Hormonal conditions across female life stages
Androgen excess and insulin resistance causing irregular cycles, acne, and fertility challenges. Affects 8–13% of women.
Estrogen-driven tissue growth outside the uterus. Often takes 7–10 years to diagnose. Affects ~10% of women.
Severe luteal-phase mood disruption driven by sensitivity to progesterone changes. Distinct from PMS. Affects 3–8% of women.
New-onset depression in the 40s is frequently hormonal in origin — estrogen regulates serotonin and norepinephrine.
Bone density falls sharply in the first 5–7 years post-menopause without estrogen protection. DXA scan is essential.
Estrogen protects arteries. Post-menopause, CVD becomes the leading cause of death in women — exceeding breast cancer.